Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 02/19/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 287 publications

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.

Condition: Locally Advanced Squamous Cell Carcinoma of Head and Neck (LA-SCCHN)
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Treatment Used: Pembrolizumab with Concurrent Radiotherapy (RT)
Number of Patients: 133
Published: December 16, 2022

Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02).

Condition: Head and Neck Squamous Cell Carcinoma (HNSCC)
Journal: European journal of cancer (Oxford, England : 1990)
Treatment Used: Afatinib
Number of Patients: 167
Published: November 26, 2022

Efficacy and safety of apatinib in patients with recurrent or metastatic head and neck squamous cell carcinoma: a retrospective multi-center study.

Condition: Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
Journal: Scientific reports
Treatment Used: Apatinib
Number of Patients: 53
Published: November 01, 2022

First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048.

Condition: Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) in Japanese Patients
Journal: International journal of clinical oncology
Treatment Used: Pembrolizumab with or without Chemotherapy
Number of Patients: 67
Published: October 20, 2022

Efficacy of cetuximab plus PD-1 inhibitor differs by HPV status in head and neck squamous cell carcinoma: a systematic review and meta-analysis.

Condition: Human Papillomavirus (HPV)-Positive vs. Human Papillomavirus (HPV)-Negative Head and Neck Squamous Cell Carcinoma (HNSCC)
Journal: Journal for immunotherapy of cancer
Treatment Used: Cetuximab Plus PD-1 Inhibitor
Number of Patients: 802
Published: October 17, 2022

Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial.

Condition: Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Journal: Journal of experimental & clinical cancer research : CR
Treatment Used: Neoadjuvant Toripalimab Combined with Gemcitabine and Cisplatin (GP)
Number of Patients: 23
Published: October 12, 2022

A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.

Condition: Locally Advanced Squamous Cell Cancer of Head and Neck
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Treatment Used: Everolimus
Number of Patients: 52
Published: October 04, 2022

Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer.

Condition: Locally Advanced Unresectable Head and Neck Cancer
Journal: Oral oncology
Treatment Used: Radiotherapy and Cisplatin vs. Radiotherapy and Cetuximab
Number of Patients: 519
Published: September 20, 2022

Salvage Post-Operative Stereotatic Ablative Radiotherapy for Re-Current Squamous Cell Carcinoma of Head and Neck.

Condition: Recurrent Squamous Cell Carcinoma of Head and Neck (rHNC)
Journal: Medicina (Kaunas, Lithuania)
Treatment Used: Salvage Post-Operative Stereotatic Ablative Radiotherapy (PO-SABR)
Number of Patients: 11
Published: August 26, 2022

Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2).

Condition: Japanese Patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LA-SCCHN)
Journal: International journal of clinical oncology
Treatment Used: Radiotherapy Plus Cetuximab
Number of Patients: 171
Published: August 24, 2022

Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.

Condition: Advanced HPV-Negative Head and Neck Cancer
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Treatment Used: Definitive Platinum-Based Chemoradiotherapy (CRT)
Number of Patients: 513
Published: August 16, 2022

Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial.

Condition: Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Treatment Used: Neoadjuvant Chemoimmunotherapy
Number of Patients: 30
Published: June 29, 2022
Showing 1-12 of 287

Last Updated: 02/19/2023